Cyclin D1–CDK4/6 phosphorylates GTSE1 in cancer cells, preventing its degradation and sustaining high levels across the cell cycle, which enhances proliferation and correlates with poor prognosis.

Headquartered in Pleasanton, California, Boster Biological Technology is making waves in the research community with its ...

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...

The poster will include clinical data as of an April 4, 2025 data cutoff from the Company's ongoing Phase 1/2 clinical trial evaluating azenosertib in combination with encorafenib and cetuximab in ...

Factorial’s advanced solid state batteries cleared major milestones as Stellantis prepares to incorporate them into a test ...

In a social media post, Ford's head of electrified propulsion said Ford made a breakthrough in battery cell chemistry; says ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

Advancing electric mission forward, Range Rover Electric prototypes have completed a second successful season of testing and ...

“The amount of inflammation is significantly elevated in the follicular phase, or first half, of the menstrual cycle in female patients with sickle cell disease,” said lead researcher Dr ...

The Boao Lecheng International Medical Tourism Pilot Zone in Hainan province has released pricing for China's first batch of ...

Early verification of symmetry and IP placement with pattern matching technology has a profound impact on IC design ...

Scientists have developed a water-based recycling solution for perovskite solar panels, aiming to reduce environmental impact ...